Normal West alumna and current Yale Ph.D. candidate Alex Rich urges Central Illinoisans to speak up to protect research ...

In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how clinical trial sites and sponsors are responding to funding constraints by turning to telemedicine, cost-containment ...

The growth metrics depict a pessimistic decline in ICON's revenues and EBITDA for this year. However, in the last five years, ...

In this video interview, Kyle McAllister, co-founder, CEO, Trially, explains how staffing reductions caused by clinical trial budget cuts are threatening patient recruitment and retention and warns of ...

A new culture of secrecy in government is taking root — among career staffers and new political appointees alike.

The Environmental Protection Agency has placed on administrative leave 139 employees who signed a so-called “declaration of ...

Thermo Fisher's strong economic moat, slowing growth, and fair valuation. Valuation is reasonable, trading near decade-low ...

NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...

For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...

‘Frankly catastrophic’: NIH chief faces Senate questions on budget cuts that threaten Mass. By Jason Laughlin and Neena Hagen Globe Staff,Updated June 10, 2025, 11:21 a.m.

The administration’s budget proposal justified massive cuts to the NIH by citing the agency’s role in funding dangerous pathogen research that multiple intelligence agencies suspect could have ...